Pharmaphorum: Artificial intelligence in drug discovery and diagnosis

August 22, 2018

“We are turning the drug-discovery paradigm upside down by using patient-driven biology and data to derive more predictive hypotheses, rather than the traditional trial-and-error approach,” said Niven Narain, PhD., BERG’s Co-founder, President and CEO.

To read the full article, click here.

Recent news

BERG in the News!

BERG is making headlines.  Click here to see the latest breaking news, interviews, and press releases.